Sponsored Content by EvotecReviewed by Emily MageeJul 23 2026
Biomarkers are transforming how diseases are understood, diagnosed, and treated across the evolving drug development landscape
Image Credit: Shutterstock.com/TanyaJoy
Biomarkers act as a scientific bridge between molecular insights and clinical application, from supporting early target validation to guiding clinical trial design and supporting regulatory decisions.
Their role in precision medicine is particularly central, supporting tailored therapeutic approaches based on an individual patient’s or subgroup’s biological profile.
This eBook from Evotec explores the key roles of biomarkers across the drug discovery and development continuum.
Biomarkers are defined and their main types classified, including diagnostic, prognostic, safety, and patient-stratification biomarkers; target engagement and pharmacodynamic biomarkers; and surrogate endpoints. These biomarker types can inform both preclinical research and clinical development.
The eBook also examines the role of biomarkers in advancing precision medicine, including their capacity to improve treatment efficacy, reduce the risk of adverse effects, and help reduce clinical trial attrition.
Practical considerations and regulatory challenges in implementing biomarkers are also highlighted. These elements impact both clinical outcomes and commercial success, from assay validation and reproducibility to data interpretation and regulatory acceptance.
The eBook also explores emerging trends in biomarker discovery, including high-sensitivity detection, multi-omics integration, and artificial intelligence. These innovations offer new ways to improve patient stratification and better understand disease mechanisms.
Finally, a look at real-world applications features case studies and expert insights, demonstrating how biomarker-driven strategies can inform decision-making and accelerate clinical development.
Overall, this eBook offers a forward-thinking, practical overview of how biomarkers can improve patient outcomes and support advances across drug discovery and development.
Acknowledgments
Produced from materials originally authored by Evotec.
About Evotec
Evotec’s mission is to discover and develop highly effective therapeutics and make them globally available to the patients who need them. To this end, Evotec has established itself as a global platform company, leveraging its data-driven multimodality platform for both proprietary as well as partnered research, and applying a unique combination of innovative technologies for the discovery and development of first-in-class and best-in-class pharmaceutical products. Its network of partners includes all Top 20 Pharma and hundreds of biotechnology companies, academic institutions, and other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including, e.g., neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and make them accessible to patients worldwide. To-date, the Company has established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development.
Evotec operates globally with more than 4,500 highly qualified people at 17 sites in six countries across Europe and the USA. The Company’s sites in Hamburg (HQ), Cologne, Goettingen, Halle/Westphalia and Munich (Germany), Lyon and Toulouse (France), Abingdon and Alderley Park (UK), Modena and Verona (Italy), Orth (Austria), as well as in Branford, Princeton, Redmond, Seattle and Framingham (USA) offer highly synergistic technologies and services and operate as complementary clusters of excellence.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.